Becton Dickinson & Co. closed 29.02% below its 52-week high of $251.99, which the company reached on February 3rd.

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the industry. The only way you can have any growth is buy it.

Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...

The dialysis market is projected to grow at a CAGR of approximately 8% during the forecast period. This growth is driven by ...

Shares of West Pharmaceutical Services Inc. slipped 4.83% to $210.89 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.01% to ...

View PDF Enjoy this free PDF sample of Kalorama's new report. For over 20 years, Kalorama Information has been a tr ...

Naturally, dividend stocks, especially high-yielding ones, are alluring. That said, nothing in life is guaranteed, and ...

Explore the insights of the Biopsy Devices Companies Quadrant—a comprehensive analysis of the global biopsy device market. This report evaluates over 140 companies, highlighting the top 15 leaders ...

Value trails growth, but Davenport shows how dividends, buybacks, and smart rotation can unlock upside. Learn what moves they ...

Insider buying fuels Davenport’s contrarian bets in semis, housing, and LNG. See what signals fund managers trust when ...

Overview of Sepsis Diagnostics MarketThe Global Sepsis Diagnostics Market is valued at USD 1.15 Billion in 2024 and is ...

The medtech industry holds a great deal of potential, spurred on by innovative tech. But, there are also significant ...